Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Inspire Veterinary Partners (IVPR) Liabilities and Shareholders Equity (2022 - 2025)

Historic Liabilities and Shareholders Equity for Inspire Veterinary Partners (IVPR) over the last 4 years, with Q3 2025 value amounting to $24.0 million.

  • Inspire Veterinary Partners' Liabilities and Shareholders Equity rose 696.57% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.6 million, marking a year-over-year decrease of 434.15%. This contributed to the annual value of $20.2 million for FY2024, which is 731.95% down from last year.
  • Inspire Veterinary Partners' Liabilities and Shareholders Equity amounted to $24.0 million in Q3 2025, which was up 696.57% from $20.8 million recorded in Q2 2025.
  • Inspire Veterinary Partners' Liabilities and Shareholders Equity's 5-year high stood at $24.0 million during Q3 2025, with a 5-year trough of $20.2 million in Q4 2022.
  • Over the past 4 years, Inspire Veterinary Partners' median Liabilities and Shareholders Equity value was $21.5 million (recorded in 2023), while the average stood at $21.7 million.
  • In the last 5 years, Inspire Veterinary Partners' Liabilities and Shareholders Equity soared by 795.26% in 2023 and then plummeted by 1168.66% in 2025.
  • Over the past 4 years, Inspire Veterinary Partners' Liabilities and Shareholders Equity (Quarter) stood at $20.2 million in 2022, then grew by 7.95% to $21.8 million in 2023, then dropped by 7.32% to $20.2 million in 2024, then grew by 18.62% to $24.0 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $24.0 million for Q3 2025, versus $20.8 million for Q2 2025 and $20.7 million for Q1 2025.